Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation
在携带 STK11 或 KEAP1 突变的晚期非小细胞肺癌患者中,阿特珠单抗较多西他赛可延长总生存期。
期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2020.1865670
Nie, Wei; Gan, Lu; Wang, Xin; Gu, Kai; Qian, Fang-Fei; Hu, Min-Juan; Zhang, Ding; Chen, Shi-Qing; Lu, Jun; Cao, Shu-Hui; Li, Jing-Wen; Wang, Yue; Zhang, Bo; Wang, Shu-Yuan; Li, Chang-Hui; Yang, Ping; Xu, Mi-Die; Zhang, Xue-Yan; Zhong, Hua; Han, Bao-Hui